0.6241
Plus Therapeutics Inc Aktie (PSTV) Neueste Nachrichten
Is Plus Therapeutics Inc. (XMP0) stock protected from inflationJuly 2025 Reactions & Accurate Buy Signal Alerts - newser.com
Plus Therapeutics (PSTV) Receives Analyst Rating of 'Buy' from D. Boral Capital | PSTV Stock News - GuruFocus
Plus Therapeutics (PSTV) Progresses with CNSide Diagnostic Launc - GuruFocus
Plus Therapeutics Signs Lease Agreement in Houston - TipRanks
Plus Therapeutics, Inc. Expands Commercial Footprint and Appoints New Leadership for CNSide Diagnostic Business - Quiver Quantitative
Plus Therapeutics Updates on CNSide® Diagnostic Platform Launch - Stock Titan
PSTV enters Houston facility lease with ~3% annual rent increases - Stock Titan
Published on: 2025-10-21 04:40:09 - newser.com
Applying Elliott Wave Theory to Plus Therapeutics Inc.2025 Sector Review & Safe Entry Point Alerts - newser.com
Combining price and volume data for Plus Therapeutics Inc.Weekly Gains Report & Smart Money Movement Tracker - newser.com
Should you hold or exit Plus Therapeutics Inc. now2025 AllTime Highs & Free Technical Confirmation Trade Alerts - newser.com
Published on: 2025-10-21 08:07:06 - nchmf.gov.vn
Published on: 2025-10-20 19:48:31 - newser.com
Why Plus Therapeutics Inc. stock could outperform in 2025Weekly Stock Report & Fast Moving Stock Watchlists - newser.com
Analysis Recap: Can Plus Therapeutics Inc. (XMP0) stock stage a strong rebound this quarterMarket Trend Review & Weekly Watchlist for Consistent Profits - nchmf.gov.vn
Buybacks Report: Is Plus Therapeutics Inc. (XMP0) stock protected from inflationForecast Cut & AI Powered Buy and Sell Recommendations - nchmf.gov.vn
Published on: 2025-10-20 23:29:07 - nchmf.gov.vn
PLUS THERAPEUTICS, Inc. (PSTV) Stock forecasts - Yahoo
How Plus Therapeutics Inc. (XMP0) stock moves on employment dataEarnings Growth Summary & Safe Entry Trade Signal Reports - newser.com
Plus Therapeutics Inc (XMP0.MU) stock price, news, quote and history - Yahoo
Candlestick signals on Plus Therapeutics Inc. stock today2025 Technical Overview & Growth Focused Stock Reports - newser.com
Using Ichimoku Cloud for Plus Therapeutics Inc. technicalsJuly 2025 EndofMonth & Reliable Price Breakout Alerts - newser.com
Identifying reversal signals in Plus Therapeutics Inc.Trade Volume Report & High Conviction Buy Zone Picks - newser.com
Is Plus Therapeutics Inc. stock entering bullish territoryJuly 2025 PreEarnings & Fast Entry High Yield Tips - newser.com
Why Plus Therapeutics Inc. stock remains on watchlists2025 Sector Review & AI Powered Market Entry Ideas - newser.com
Plus Therapeutics Inc. stock outlook for YEAREarnings Trend Report & Daily Growth Stock Tips - newser.com
Combining machine learning predictions for Plus Therapeutics Inc.Weekly Trade Analysis & Weekly High Conviction Ideas - newser.com
Real time scanner hits for Plus Therapeutics Inc. explainedTrade Risk Summary & Technical Buy Zone Confirmations - newser.com
Order flow analysis tools used on Plus Therapeutics Inc.2025 Volatility Report & Free Weekly Watchlist of Top Performers - newser.com
Will Plus Therapeutics Inc. stock benefit from infrastructure spendingForecast Cut & Weekly Chart Analysis and Trade Guides - nchmf.gov.vn
Will Plus Therapeutics Inc. stock see insider buyingChart Signals & Verified Swing Trading Watchlists - nchmf.gov.vn
Can Plus Therapeutics Inc. stock beat market expectations this quarter2025 Earnings Impact & Risk Adjusted Buy and Sell Alerts - Trung tâm Dự báo KTTV quốc gia
What MACD and RSI say about Plus Therapeutics Inc.2025 Key Lessons & Technical Pattern Based Signals - newser.com
Top chart patterns to watch in Plus Therapeutics Inc.2025 Trading Recap & Weekly Watchlist for Hot Stocks - newser.com
Why Plus Therapeutics Inc. is moving todayTrade Risk Report & Free Real-Time Volume Trigger Notifications - newser.com
What momentum shifts mean for Plus Therapeutics Inc.July 2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com
Cellular Immunotherapy Breakthroughs Fuel $370 Billion Market Surge - MarketScreener
Zacks Industry Outlook Highlights Akebia Therapeutics, Ironwood Pharmaceuticals, Pyxis Oncology, Cardiol Therapeutics and Plus Therapeutics - Yahoo Finance
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):